SCHEMBL573521

SCHEMBL573521

COC(=O)c1cc([N+](=O)[O-])c(Cl)c(S(N)(=O)=O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VCAM1 P19320 1/20 0.54
▸ POLB P06746 4/20 0.46
▸ ALDH1A1 P00352 6/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ MAPT P10636 5/20 0.45
▸ GAA P10253 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ LMNA P02545 1/20 0.43
▸ HPGD P15428 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ TPMT P51580 1/20 0.42
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7822590 0.88 VCAM1 (0.67) VCAM1POLBALDH1A1MAPTKDM4E
SCHEMBL11389391 0.88 VCAM1 (0.56) VCAM1POLBALDH1A1MAPTGAA
SCHEMBL11855920 0.86 ALDH1A1 (0.50) POLBALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL573855 0.84 VCAM1 (0.52) VCAM1POLBALDH1A1CYP1A2CYP2C19
SCHEMBL645817 0.84 VCAM1 (0.55) VCAM1POLBALDH1A1MAPTMEN1
SCHEMBL31108456 0.83 ALDH1A1 (0.57) VCAM1POLBALDH1A1CYP1A2CYP2D6
SCHEMBL573259 0.83 ALDH1A1 (0.57) VCAM1POLBALDH1A1CYP1A2CYP2D6
SCHEMBL13543308 0.82 ALDH1A1 (0.47) VCAM1ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL31016374 0.81 TPMT (0.54) VCAM1POLBMAPTGAAL3MBTL1
SCHEMBL7573734 0.81 TPMT (0.54) VCAM1POLBMAPTGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
EP-0699185-B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO (JP) 2001-09-05 — — EP disclosed
US-5824691-A CARDIOVASCULAR, CEREBROVASCULAR, RENAL DISEASES; SHOCK, ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-10-20 — — US disclosed
EP-0699185-A1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-03-06 — — EP disclosed
WO-1994026709-A1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+/H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-24 — — WO disclosed
Send feedback